Eureka Genomics Wins DHS Anthrax Detection Grant | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bioinformatics company Eureka Genomics has reeled in a $750,000 Phase II Small Business Innovation Research grant from the Department of Homeland Security to continue to develop tools to detect rare variants of the anthrax pathogen Bacillus anthracis.

Houston-based Eureka is a private firm that develops next-generation sequencing analysis tools for use in discovering microorganisms associated with disease. It also provides sequencing and analysis services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.